Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001699:Biometry; D002318:Cardiovascular Diseases / Q000401:mortality; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000178:diet therapy / Q000188:drug therapy*; D003927:Diet, Diabetic; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006321:Heart / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D008962:Models, Theoretical; D009874:Operations Research; D010629:Phenformin / Q000627:therapeutic use; D010919:Placebos; D012737:Sex Factors; D013997:Time Factors; D014044:Tolbutamide / Q000009:adverse effects / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D010919:Placebos; D014044:Tolbutamide; D010629:Phenformin